PortfoliosLab logoPortfoliosLab logo
ORCP.L vs. NTLA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ORCP.L vs. NTLA - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Oracle Coalfields plc (ORCP.L) and Intellia Therapeutics, Inc. (NTLA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

ORCP.L is traded in GBp, while NTLA is traded in USD. To make them comparable, the NTLA values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, ORCP.L achieves a 26.67% return, which is significantly lower than NTLA's 35.39% return. Over the past 10 years, ORCP.L has underperformed NTLA with an annualized return of -34.46%, while NTLA has yielded a comparatively higher -7.14% annualized return.


ORCP.L

1D
0.00%
1M
-13.32%
YTD
26.67%
6M
35.71%
1Y
187.88%
3Y*
-29.83%
5Y*
-36.90%
10Y*
-34.46%

NTLA

1D
-1.86%
1M
-11.95%
YTD
35.39%
6M
33.93%
1Y
47.54%
3Y*
-37.21%
5Y*
-31.62%
10Y*
-7.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ORCP.L vs. NTLA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ORCP.L
Oracle Coalfields plc
26.67%56.25%-26.15%-84.15%-55.91%-11.43%-52.27%131.58%-74.67%-34.21%
NTLA
Intellia Therapeutics, Inc.
35.39%-28.39%-61.09%-16.98%-66.98%119.41%259.93%3.38%-24.77%33.93%

Correlation

The correlation between ORCP.L and NTLA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.05

Correlation (10Y)
Calculated over the trailing 10-year period

0.06

Correlation (All Time)
Calculated using the full available price history since May 6, 2016

0.06

Fundamentals

Market Cap

ORCP.L:

£5.20M

NTLA:

$1.43B

EPS

ORCP.L:

-£0.00

NTLA:

-$3.58

PB Ratio

ORCP.L:

0.78

NTLA:

2.31

Total Revenue (TTM)

ORCP.L:

£0.00

NTLA:

$66.09M

Gross Profit (TTM)

ORCP.L:

-£171.00

NTLA:

-$33.92M

EBITDA (TTM)

ORCP.L:

-£1.17M

NTLA:

-$299.32M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ORCP.L vs. NTLA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ORCP.L
ORCP.L Risk / Return Rank: 8484
Overall Rank
ORCP.L Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
ORCP.L Sortino Ratio Rank: 8888
Sortino Ratio Rank
ORCP.L Omega Ratio Rank: 8787
Omega Ratio Rank
ORCP.L Calmar Ratio Rank: 8888
Calmar Ratio Rank
ORCP.L Martin Ratio Rank: 8080
Martin Ratio Rank

NTLA
NTLA Risk / Return Rank: 6060
Overall Rank
NTLA Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
NTLA Sortino Ratio Rank: 6363
Sortino Ratio Rank
NTLA Omega Ratio Rank: 6565
Omega Ratio Rank
NTLA Calmar Ratio Rank: 5757
Calmar Ratio Rank
NTLA Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORCP.L vs. NTLA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oracle Coalfields plc (ORCP.L) and Intellia Therapeutics, Inc. (NTLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ORCP.LNTLADifference
Sharpe ratioReturn per unit of total volatility

+0.58

Sortino ratioReturn per unit of downside risk

+1.57

Omega ratioGain probability vs. loss probability

1.36

1.19

+0.17

Calmar ratioReturn relative to maximum drawdown

3.72

0.67

+3.05

Martin ratioReturn relative to average drawdown

6.20

1.04

+5.16

ORCP.L vs. NTLA - Sharpe Ratio Comparison

The current ORCP.L Sharpe Ratio is 1.08, which is higher than the NTLA Sharpe Ratio of 0.50. The chart below compares the historical Sharpe Ratios of ORCP.L and NTLA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ORCP.L vs. NTLA - Drawdown Comparison

The maximum ORCP.L drawdown since its inception was -99.92%, roughly equal to the maximum NTLA drawdown of -96.14%. Use the drawdown chart below to compare losses from any high point for ORCP.L and NTLA.


Loading charts...

Drawdown Indicators


ORCP.LNTLADifference

Max Drawdown

Largest peak-to-trough decline

-99.92%

-96.14%

-3.78%

Max Drawdown (1Y)

Largest decline over 1 year

-50.15%

-70.63%

+20.48%

Max Drawdown (3Y)

Largest decline over 3 years

-90.92%

-86.05%

-4.87%

Max Drawdown (5Y)

Largest decline over 5 years

-97.95%

-96.14%

-1.81%

Max Drawdown (10Y)

Largest decline over 10 years

-99.67%

-96.14%

-3.53%

Current Drawdown

Current decline from peak

-99.67%

-92.92%

-6.75%

Average Drawdown

Average peak-to-trough decline

-89.55%

-54.52%

-35.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.16%

45.77%

-15.61%

Volatility

ORCP.L vs. NTLA - Volatility Comparison

The current volatility for Oracle Coalfields plc (ORCP.L) is 21.24%, while Intellia Therapeutics, Inc. (NTLA) has a volatility of 23.83%. This indicates that ORCP.L experiences smaller price fluctuations and is considered to be less risky than NTLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ORCP.LNTLADifference

Volatility (1M)

Calculated over the trailing 1-month period

21.24%

23.83%

-2.59%

Volatility (6M)

Calculated over the trailing 6-month period

96.10%

53.56%

+42.54%

Volatility (1Y)

Calculated over the trailing 1-year period

173.45%

95.98%

+77.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

142.23%

79.73%

+62.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

134.31%

77.77%

+56.54%

Dividends

ORCP.L vs. NTLA - Dividend Comparison

Neither ORCP.L nor NTLA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ORCP.L vs. NTLA - Financials Comparison

This section allows you to compare key financial metrics between Oracle Coalfields plc and Intellia Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-5.00M0.005.00M10.00M15.00M20.00M25.00M30.00M2021202220232024202520260
15.05M
(ORCP.L) Total Revenue
(NTLA) Total Revenue
Please note, different currencies. ORCP.L values in GBP, NTLA values in USD

Frequently Asked Questions


ORCP.L and NTLA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ORCP.L and NTLA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer